Cancers that have a deletion in the 9p21 section of their genomes tend to have worse outcomes for patients and increased resistance to immunotherapy. A new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer. In mouse models of melanoma, bladder cancer, leukemia and colon cancer, the drug slows the growth of tumors, extends lifespan and boosts the efficacy of immunotherapy.
A new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer, a team led by researchers at The University of Texas at Austin has found. In mouse models of melanoma, bladder cancer, leukemia and colon cancer, the drug slows the growth of tumors, extends lifespan and boosts the efficacy of immunotherapy.
Stone envisions the drug being used in combination with immunotherapies to boost their effectiveness. To create their drug candidate, Stone and his colleagues started with the helpful enzyme that's naturally produced by the body to break down MTA and then added flexible polymers. The study's other co-authors from UT are Kendra Garrison, Candice Lamb, Yuri Tanno and George Georgiou. The study's co-corresponding authors are Stone and David Kwiatkowski, a senior physician at Brigham and Women's Hospital and a professor of medicine at Harvard Medical School.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Cancer survivors rock the runway at 13th annual Think Pink fashion showBreast cancer survivors rocked the runway Sunday as part of USA Health Mitchell Cancer Institute’s Think Pink Tea in support of breast cancer awareness.
続きを読む »
Woman With Breast Cancer at 34 Had To Fight For MammogramMeghan Holohan is a contributing writer who covers health and parenting for TODAY.com. She enjoys cooking, yoga, reading, music and walking her two rescue dogs. Follow her on Twitter to see her recent stories.
続きを読む »
Chicago high school security officer beats cancer, set to compete in marathonTens of thousands of athletes will run in the Bank of America Chicago Marathon on Sunday, each one with a special reason for why they're pushing themselves to finish.
続きを読む »
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 BillionDeal expands pharmaceutical company’s portfolio of cancer drugs
続きを読む »
Hundreds gather in Dallas to raise cancer awareness among LatinxBreaking news and the latest headlines from North Texas, including Dallas, Plano, Frisco, McKinney, Arlington, Irving and beyond. Politics, education, transportation, housing, crime and more.
続きを読む »